Neurological Disclaimer: Injectable glutathione is not approved for the treatment, prevention, or cure of any neurological condition including cognitive decline, neurodegenerative diseases, or mood disorders
Of note, only small number of sudies investigated this outcome with heterogenity in inclusion criteria among study populations, and differences in AOX combinations and SDF assays used
Administer (in research models)
Active compounds with potential pro-cognitive effects were assigned to substances of plant/fungus origin (botanicals) or synthetic substances
In the context of a restricted assay-format, in which implication of free LASSS can be excluded, the outcomes may provide critical insights towards understanding of an underlying LASSS-driven mechanism
IV glutathione bypasses this degradation but has a half-life of only 1030 minutes, limiting sustained effect